Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells

Area of Science:

• Cardiovascular Biology
• Endothelial Function
• Lipoprotein Metabolism

Background:

• Apolipoprotein E (apoE) exists in three common isoforms: apoE2, apoE3, and apoE4.
• ApoE3 is generally considered atheroprotective, while apoE2 and apoE4 are associated with hyperlipidemias.
• The differential effects of apoE isoforms on endothelial function are not fully understood.

Purpose of the Study:

• To investigate the isoform-dependent effects of apolipoprotein E (apoE) on nitric oxide (NO) release in human endothelial cells.
• To elucidate the signaling pathways involved in apoE-mediated NO production.

Main Methods:

• Utilized a fluorescent assay to measure nitric oxide release from cultured human EA.hy926 endothelial cells stimulated with recombinant apoE isoforms (apoE2, apoE3, apoE4).
• Investigated the role of phosphatidylinositol (PI) 3-kinase signaling by using specific inhibitors.
• Assessed the tyrosine phosphorylation status of apoE receptor 2 (apoER2) in response to apoE stimulation.

Main Results:

• Recombinant apoE3 particles significantly increased nitric oxide release in endothelial cells compared to apoE2 and apoE4.
• ApoE3 stimulated 141% more nitric oxide release than controls, while apoE2 and apoE4 showed smaller increases (61% and 11%, respectively).
• Inhibition of PI3-kinase suppressed the apoE-mediated increase in nitric oxide release, and apoER2 tyrosine phosphorylation was observed.

Conclusions:

• Apolipoprotein E stimulates endothelial nitric oxide release in an isoform-dependent manner, with apoE3 being the most potent.
• Tyrosine phosphorylation of apoE receptor 2 (apoER2) is a key event initiated by apoE.
• This phosphorylation likely triggers PI3-kinase signaling, leading to the activation of nitric oxide synthase and subsequent NO production.